From October 1, 2022 to January 24, 2023, the company has repurchased 15,700,269 shares, representing 29.44% for $12.5 million. With this, the company has completed the repurchase of 15,700,269 shares, representing 29.44% for $12.5 million under the buyback announced on May 31, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3222 USD | -2.36% |
|
+2.32% | -20.05% |
Jul. 09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
Jul. 09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.05% | 10.66M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.76% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+4.00% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- TNXP Stock
- TNXP Stock
- News Tonix Pharmaceuticals
- Tranche Update on Tonix Pharmaceuticals Holding Corp.'s Equity Buyback Plan announced on May 31, 2022.